Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Debt to Equity: 2016-2024

Historic Debt to Equity for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to $2.69.

  • Collegium Pharmaceutical's Debt to Equity fell 22.88% to $2.07 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.63, marking a year-over-year increase of 18.05%. This contributed to the annual value of $2.69 for FY2024, which is 29.73% up from last year.
  • Collegium Pharmaceutical's Debt to Equity amounted to $2.69 in FY2024, which was up 29.73% from $2.07 recorded in FY2023.
  • Over the past 5 years, Collegium Pharmaceutical's Debt to Equity peaked at $2.87 during FY2022, and registered a low of $0.54 during FY2021.
  • In the last 3 years, Collegium Pharmaceutical's Debt to Equity had a median value of $2.69 in 2024 and averaged $2.55.
  • Its Debt to Equity has fluctuated over the past 5 years, first spiked by 543.73% in 2020, then plummeted by 35.97% in 2021.
  • Yearly analysis of 5 years shows Collegium Pharmaceutical's Debt to Equity stood at $0.85 in 2020, then plummeted by 35.97% to $0.54 in 2021, then spiked by 430.20% to $2.87 in 2022, then declined by 27.90% to $2.07 in 2023, then increased by 29.73% to $2.69 in 2024.